Improve Your Commercial Growth Strategy with Custom-Tailored Intelligence

LEARN MORE

Chart of the Week: Alzheimer’s Biomarker and Trial Landscape

by

This week’s CotW includes the landscape of biomarkers and clinical trials for Alzheimer’s disease.  There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials.
Gray: Disease
Blue: Biomarkers
Purple: Clinical Trials
Yellow: FDA Cleared and Approved Tests

AlzGraph.png

PageLines